<DOC>
	<DOCNO>NCT01080781</DOCNO>
	<brief_summary>- Background : Ephrin-B1 part large Eph/Ephrin system involve cell-cell comunication . The role Ephrin-B1 scarcely study adulthood . Our team show protein express normal heart mouse human . In mice deletion gene encode Ephrin-B1 , show progressive development dilate cardiomyopathy characterize dramatic disorganization cardiac tissue architecture decrease heart rate variability . - Purpose : Ephrin-B1 protein recently identify human heart putative role remain unknown . In knockout mouse , deletion efn gene associate abnormality cardiac architecture link defect cell-cell tight junction . From functional point view , mouse develop dilate cardiomyopathy exhibit decreased heart rate variability frequency domain . The purpose study ass Ephrin-B1 expression regulate human heart expression level correlate heart rate variability . - Abstract : Thirty patient suffer cardiac disease need surgery include separate two group accord pressure level right auricle /and pulmonary artery . Ephrin-B1 expression assess right appendage transcriptional ( quantitative PCR ) protein ( Western blot ) level . Furthermore , putative relationship Ephrin-B1 expression heart rate variability ( 24 hour ECG recording ) investigate .</brief_summary>
	<brief_title>Ephrin B1 Regulation Human Right Appendage</brief_title>
	<detailed_description>- Outcomes - Primary : Expression level gene encode Ephrin B1 ( quantitative PCR normalize GAPDH gene expression ) human right appendage biopsy - Secondary : a/ Expression level Ephrin B1 protein human right appendage use Western blot b/ Heart rate variability time spectral domain - Study design : Exploratory , monocentric , prospective comparative . Two group 15 patient , age sex match , without elevate pressure right auricle pulmonary artery include . - Eligibility criterion : - Inclusion criterion : patient need cardiac surgery right catheterism 24 hour ECG record inclusion ; stable medication least 4 week ; age &gt; 18 year . - Exclusion criterion : Patient pace-maker atrial fibrillation - Number subject : 30 patient two group 15 patient . - Statistical analysis : Qualitative quantitative variable compare use McNemar test test respectively . A p value &lt; 0.05 consider significant .</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<criteria>Patients need cardiac surgery right cardiac catheterism 24 hour ECG record inclusion Stable medication least 4 week Patient pacemaker atrial fibrillation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Cardiomyopathy</keyword>
	<keyword>Ephrin-B1 expression</keyword>
	<keyword>cell-cell junction</keyword>
	<keyword>heart rate variability</keyword>
	<keyword>right appendage</keyword>
</DOC>